Familial polyposis coli: Clinical manifestations, evaluation, management and treatment

Mount Sinai Journal of Medicine

Volumn 71, Issue 6, 2004, Pages 384-391

  Nandakumar, Govind ^a   Morgan, Jeffrey A ^a   Silverberg, Daniel ^a   Steinhagen, Randolph M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Desmoid tumors; Familial adenomatous polyposis; Gardner; Hereditary colon cancer

Indexed keywords

ALPHA TOCOPHEROL; APC PROTEIN; ASCORBIC ACID; CARBOPLATIN; DACARBAZINE; DOXORUBICIN; METHOTREXATE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULINDAC; TAMOXIFEN; TOREMIFENE; URSODEOXYCHOLIC ACID; VINBLASTINE;

ABDOMINAL PAIN; ADENOMATOUS POLYP; AUTOSOMAL DOMINANT INHERITANCE; BLEEDING; CLINICAL TRIAL; COLON; COLON CANCER; COLORECTAL CARCINOMA; DESMOID TUMOR; DIARRHEA; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOSCOPY; EPIDERMOID CYST; EPISTAXIS; FAMILIAL COLON POLYPOSIS; FEBRILE NEUTROPENIA; GARDNER SYNDROME; GENE MUTATION; HUMAN; ILEUM POUCH; MORBIDITY; MORTALITY; NAUSEA AND VOMITING; OSTEOMA; PROCTOCOLECTOMY; RECTUM; REVIEW; SOFT TISSUE TUMOR; STOMA; STOMATITIS; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THYROID CANCER; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADULT; FEMALE; FIBROMATOSIS, ABDOMINAL; GARDNER SYNDROME; GENES, APC; HUMANS; PROCTOCOLECTOMY, RESTORATIVE;

EID: 10944224601     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52(1):23-47. Errata in CA Cancer J Clin 2002; 52(2):119 and CA Cancer J Clin 2002; 52(3):181-182.
2. Wennstrom J, Pierce ER, McKusick VA. Hereditary benign and malignant lesions of the large bowel. Cancer 1974; 34(3):Suppl:850-857.
3. Bussey HJR. Familial polyposis coli. Family studies, histopathology, differential diagnosis and results of treatment. Baltimore (MD): Johns Hopkins University Press; 1975.
4. Bulow S. Familial polyposis coli. Danish Med Bull 1987; 34:1-15.
5. Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1990; 100:1658-1664.
6. Hamilton ST, Liu B, Parsons RD, et al. The molecular basis of Turcot syndrome. N Engl J Med 1995; 332:839-847.
7. Laurent-Puig P, Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1998; 26:269-270.
8. Debinski HS, Love S, Spigelman AD, Phillips RK. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996; 110(4):1028-1030.
9. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66(3):589-600.
10. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253(5020):661-665.
11. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253(5020):665-669.
12. Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin North Am 2002; 86(6):1467-1495.
13. Kaplan KB, Burds AA, Swedlow JR, et al. A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 2001; 3:429-432.
14. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87(2):159-170.
15. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003; 124(6):1574-1594.
16. Olschwang S, Tiret A, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75:959-968.
17. Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4:337-340.
18. Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am 2002; 31(4):1107-1131.
19. Cruz-Correa M, Giardiello FM. Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am 2002; 31(2):537-549.
20. Gardner EJ. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Amer J Hum Genet 1951; 3:167-176.
21. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348(10):919-932.
22. Corman LM. Colon and rectal surgery. Philadelphia and New York: Lippincott-Raven; 1998.
23. Smith WG. Desmoid tumors in familial multiple polyposis. Mayo Clin Proc 1959; 34:31-38.
24. Gorlin RJ, Chaudhary AP. Multiple osteomatosis, fibromas, lipomas and fibrosarcomas of the skin and mesentery, epidermoid inclusion cysts of the skin, leiomyomas and multiple intestinal polyposis: a heritable disorder of connective tissue. N Engl J Med 1960; 263:1151-1158.
25. McAdam WAF, Goligher JC. The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 1970; 57:618-631.
26. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumors in familial adenomatous polyposis. Gut 1994; 35(3):377-381.
27. Jones IT, Jagelman DG, Fazio VW, et al. Desmoid tumors in familial polyposis coli. Ann Surg 1986; 204(1):94-97.
28. Garber JE, Li FP, Kingston JE, et al. Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst 1988; 80(20):1626-1628. Erratum in J Natl Cancer Instit 1989; 81(6):461.
29. LeSher AR, Castronuovo JJ Jr, Filippone AL Jr. Hepatoblastoma in a patient with familial polyposis coli. Surgery 1989; 105(5):668-670.
30. Plail RO, Bussey HJ, Glazer G, Thomson JP. Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg 1987; 74(5):377-380.
31. Walsh N, Qizilbash A, Banerjee R, Waugh GA. Biliary neoplasia in Gardner's syndrome. Arch Pathol Lab Med 1987; 111(1):76-77.
32. Sugihara K, Tetsuichiro M, Kamiya J, et al. Gardner's syndrome associated with periampullary carcinoma, duodenal and gastric adenomatosis: report of a case. Dis Colon Rectum 1982; 25:766-771.
33. Leppard B. Epidermoid cysts and polyposis coli. Proc R Soc Med 1974; 67:1036-1037.
34. Utsunomiya J, Nakamura T. The occult osteomatous changes in the mandible in patients with familial polyposis coli. Br J Surg 1975; 62:45-51.
35. Watne AL, Core SK, Carrier JM. Gardner's syndrome. Surg Gynecol Obstet 1975; 141:53-56.
36. Blair NP, Trempe CL. Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome. Am J Ophthalmol 1980; 90(5):661-667.
37. King JE, Dozois RR, Lindor NM, Ahlquist DA. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 2000; 75(1):57-67.
38. Cromwell DM, Moore RD, Brensinger JD, et al. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis. Gastroenterology 1998; 114: 893-901.
39. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329:1982-1987.
40. Cronkhite LW, Canada WJ. Generalized gastrointestinal polyposis. Unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 1955; 252: 1011-1615.
41. Helwig EB. Adenomas and the pathogenesis of cancer of the colon and rectum. Dis Colon rectum 1959; 2(1):5-17.
42. Henry LG, Condon RE, Schulte WJ, et al. Risk of recurrence of colon polyps. Ann Surg 1975; 182:511-514.
43. Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis. N Engl J Med 2002; 346:1054-1059.
44. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cycylooxygenase-2 inhibitor in familial adenomatous polyposis. N Engl J Med 2000; 342:1946-1952.
45. Rhodes M, Bradburn DM. Overview of screening and management of familial adenomatous polyposis. Gut 1992; 33:125-131.
46. Berk T, Cohen Z. Hereditary gastrointestinal polyposis syndromes. In: Nicholls RJ, Dozois RR, editors. Surgery of the colon and rectum. New York: Churchill Livingstone Publishing; 1997. pp. 390-410.
47. Prudhomme M, Farouk R, Dozois RR. Complications after ileal pouch-anal canal anastomosis. Perspect Colon Rectal Surg 1999; 11:57-68.
48. Nyam DC, Brillant PT, Dozois RR, et al. Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results. Ann Surg 1997; 226(4):514-521.
49. Parc YR, Moslein G, Dozois RR, et al. Familial adenomatous polyposis: results following ileal pouch-anal anastomosis in teenagers. Dis Colon Rectum. 2000; 43(7):893-902.
50. Church J, Simmang C. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 2003; 46:1001-1012.
51. van Duijvendijk P, Vasen HF, Bertario L, et al. Cumulative risk of developing polyps of malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 1999; 3(3):325-330.
52. Remzi FH, Church JM, Bast J, et al. Mucosectomy vs. stapled ileal pouch-anal anastomosis in patients with familial adenomatous polyposis: functional outcome and neoplasia control. Dis Colon Rectum 2001; 44:1590-1596.
53. Fazio VW, Tjandra JJ. Transanal mucosectomy: ileal pouch advancement for anorectal dysplasia or inflammation after restorative proctocolectomy. Dis Colon Rectum 1994; 37:1008-1011.
54. Gingold BS, Jagelman DG. Sparing the rectum in familial polyposis: causes for failure. Surgery 1981; 89:314-318.
55. Gingold BS, Jagelman DG, Turnbull RB Jr. Surgical management of familial polyposis and Gardner's syndrome. Am J Surg 1979; 137:54-56.
56. Cole JW, Holden WD. Postcolectomy regression of adenomatous polyps of the rectum. Arch Surg 1959; 79:385-392.
57. Hubbard TB Jr. Familial polyposis of the colon: the fate of the retained rectum after colectomy in children. Am Surg 1957; 23:577-580.
58. Lacolio SA. Spontaneous disappearance of rectal polyps following subtotal colectomy and ileoproctostomy for polyposis of the colon. Am J Surg 1962; 103:81-82.
59. Sheppard JA. Familial polyposis of the colon with special reference to regression of rectal polyposis after subtotal colectomy. Br J Surg 1971; 58:85-91.
60. Jang YS, Steinhagen RM, Heimann TM. Colorectal cancer in familial adenomatous polyposis. Dis Colon Rectum 1997; 40:312-316.
61. Tonelli F, Valanzano R, Monaci I, et al. Restorative proctocolectomy of rectum-preserving surgery in patients with familial adenomatous polyposis: results of prospective study. World J Surg 1997; 21(6):653-659.
62. Salemans JM, Nagengast M. Clinical and physiological aspects of ileal pouch-anal anastomosis. Scand J Gastroenterol Suppl 1995; 212:3-12.
63. Kartheuser AH, Parc R, Penna CP, et al. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. Surgery 1996; 119(6):615-623.
64. Jones IT, Fazio VW, Weakley FL, et al. Desmoid tumors in familial polyposis coli. Ann Surg 1986; 204:94-97.
65. Heiskanen I, Jarvinen HJ. Occurrence of desmoid tumors in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996; 11:157-162.
66. Soravia C, Berk T, McLeod RS, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Col Rectum 2000; 43(3):363-369.
67. Clark SK, Phillips RK. Desmoids in familial adenomatous polyposis. Br J Surg 1996; 83(11):1494-1504.
68. Lofti AM, Dozois RR, Gordon H, et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 1989; 4:30-36.
69. Penna C, Tiret E, Parc R, et al. Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet 1993; 177:263-268.
70. Rodriguez-Bigas MA, Mahoney MC, Karakousis CD, Petrelli NJ. Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994; 74:1270-1274.
71. Kadmon M, Möslein G, Buhr H, Herfarth C. Desmoide bei Patienten mit familiärer adenomatöser Polyposis (FAP) [German]. Chirurg 1995; 66(10):997-1005.
72. Kitamura A, Kanagawa T, Yamada S, Kawai T. Effective chemotherapy for abdominal desmoid tumor in a patient with Gardner's syndrome: report of a case. Dis Colon Rectum 1991; 34:822-826.
73. Lynch HT, Fitzgibbons R Jr, Chong S, et al. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994; 37:260-267.
74. Kiel KD, Suit HD. Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer 1984; 54(10):2051-2055.
75. Sagar PM, Möslein G, Dozois RR. Management of desmoid tumors in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1998; 41:1350-1355.
76. Browning SM, Nivatvongs S. Intraoperative reasons for abandoning ileal pouch to anal anastomosisCthe Mayo Clinic experience. J Am Coll Surg 1998; 186(4):441-446.
77. Chun H, Smith LE, Orkin BA. Intraoperative reasons for abandoning ileal pouch-anal anastomosis procedures. Dis Colon Rectum 1995; 38(3):273-275.
78. Chatzipetrou MA, Tzakis AG, Pinna AD, et al. Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. Surgery. 2001; 129(3):277-281.